Biomab Egfr Injection
32000 INR/Vial
Product Details:
- Pacakaging (Quantity Per Box) 1 vial
- Origin of Medicine Biotechnology / Biological
- Dosage Form Parenteral / Injectable solution
- Salt Composition Nimotuzumab
- Indication Advanced head and neck cancers, Glioma, other EGFR-expressing tumors
- Drug Type Biological / Monoclonal Antibody
- Ingredients Nimotuzumab
- Click to View more
X
Biomab Egfr Injection Price And Quantity
- 32000 INR/Vial
- 1 Vial
Biomab Egfr Injection Product Specifications
- Injection
- 1 vial
- Biotechnology / Biological
- Parenteral / Injectable solution
- Adults
- Store in a refrigerator (2C to 8C). Do not freeze.
- Nimotuzumab
- Monoclonal antibody targeting EGFR (Epidermal Growth Factor Receptor)
- As directed by the physician, typically 200mg once a week
- Biological / Monoclonal Antibody
- Advanced head and neck cancers, Glioma, other EGFR-expressing tumors
- Administer under supervision of qualified medical professional
- Patients with head and neck cancer, Glioma and certain types of other cancers expressing EGFR
- 1 vial per box
- Nimotuzumab
Product Description
Experience the ravishing promise of Biomab EGFR Injection, a triumph in oncology that brings affordable, cutting-edge care to eligible patients. Formulated with Nimotuzumab, this luxurious parenteral solution is delivered via intravenous infusion under prescription. Offered in a clear to slightly opalescent form, each 50 mg/10 ml vial is a masterpiece of biotechnology with a robust 24-month shelf life. Manufacturing excellence ensures the best price for a lavish therapy, specifically targeting advanced head and neck cancers, gliomas, and EGFR-expressing tumors. Markdown rates for dealers and wholesalers across India.
Advanced Oncology Applications - Unmatched Versatility
Biomab EGFR Injection is triumphantly designed for intravenous infusion in adults diagnosed with advanced head and neck cancer, glioma, or other EGFR-expressing tumors. Lavishly efficient when administered in combination with radiotherapy or chemotherapy, its monoclonal antibody actively targets tumor growth. The solution's clear to slightly opalescent character signals quality and purity, offering clinicians and patients a reliable parenteral product. Always use as guided by physicians for optimal results. Application is by intravenous infusion-never self-administer or inject outside clinical settings.
Seamless Sample Policy and Swift Distribution
Our sample policy ensures transparent access to Biomab EGFR Injection samples, tailored for the requirements of Indian medical professionals. With meticulous packing & dispatch protocols, each vial is shipped securely from our main domestic markets-especially across leading hospitals and medical institutions. Express shipping and reliable FOB Port handover guarantee the product's condition and timely supply. We pride ourselves on smooth order processing, supportive after-sales, and a steadfast commitment to clinical excellence for dealers, distributors, and healthcare partners.
Advanced Oncology Applications - Unmatched Versatility
Biomab EGFR Injection is triumphantly designed for intravenous infusion in adults diagnosed with advanced head and neck cancer, glioma, or other EGFR-expressing tumors. Lavishly efficient when administered in combination with radiotherapy or chemotherapy, its monoclonal antibody actively targets tumor growth. The solution's clear to slightly opalescent character signals quality and purity, offering clinicians and patients a reliable parenteral product. Always use as guided by physicians for optimal results. Application is by intravenous infusion-never self-administer or inject outside clinical settings.
Seamless Sample Policy and Swift Distribution
Our sample policy ensures transparent access to Biomab EGFR Injection samples, tailored for the requirements of Indian medical professionals. With meticulous packing & dispatch protocols, each vial is shipped securely from our main domestic markets-especially across leading hospitals and medical institutions. Express shipping and reliable FOB Port handover guarantee the product's condition and timely supply. We pride ourselves on smooth order processing, supportive after-sales, and a steadfast commitment to clinical excellence for dealers, distributors, and healthcare partners.
FAQ's of Biomab Egfr Injection:
Q: How is Biomab EGFR Injection administered?
A: Biomab EGFR Injection is administered as an intravenous infusion, typically under the supervision of a qualified healthcare professional in a hospital or clinical setting.Q: What conditions does Biomab EGFR Injection treat?
A: This medication is used for treating advanced head and neck cancers, glioma, and other tumors that express the Epidermal Growth Factor Receptor (EGFR).Q: When should Biomab EGFR Injection be avoided?
A: Biomab EGFR Injection should not be used in individuals with known hypersensitivity to Nimotuzumab or any other component of the formulation.Q: Where should Biomab EGFR Injection be stored?
A: Store Biomab EGFR Injection in a refrigerator at 2C to 8C. It should never be frozen and must be kept out of reach from unauthorized personnel.Q: What are the benefits of using Biomab EGFR Injection in cancer therapy?
A: This biological therapy specifically targets cancer cells expressing EGFR, enhancing the efficacy of radiotherapy or chemotherapy while potentially reducing side effects compared to traditional treatments.Q: How often should Biomab EGFR Injection be used?
A: The typical dosage regimen is 200 mg once a week, but actual usage must always follow the treating physician's directions based on the patient's clinical needs.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Pharmaceutical Injection' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
